EX-FILING FEES 5 d736316dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Aileron Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type
  Security
Class
Title
 

Fee
Calculation

or Carry
Forward
Rule

  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price
  Fee
Rate
 

Amount of
Registration

Fee

 

Carry
Forward

Form

Type

 

Carry
Forward

File
Number

 

Carry
Forward

Initial

Effective

Date

 

Filing Fee

Previously

Paid In

Connection

with Unsold

Securities to
be

Carried

Forward

 
Newly Registered Securities
                         

Fees to Be

Paid

  Equity  

Common
Stock, $0.001

par value per
share

  Other   7,060,500 (1)   $4.01 (2)   $28,312,605.00 (2)   0.00014760   $4,178.95          
                         

Fees

Previously

Paid

                         
 
Carry Forward Securities
                         

Carry

Forward

Securities

                       
                   
    Total Offering Amounts      $28,312,605.00 (2)     $4,178.95          
                   
    Total Fees Previously Paid                   
                   
    Total Fee Offsets                   
                   
    Net Fee Due                $4,178.95                

 

(1)

The shares of common stock will be offered for resale by the selling stockholders pursuant to the prospectus contained in the registration statement to which this exhibit is attached. The registration statement registers the resale of an aggregate of 7,060,500 shares of the Registrant’s common stock, which consists of (i) 4,707,000 shares of common stock issuable upon the conversion of the Registrant’s Series X Non-Voting Convertible Preferred Stock (the “Series X Preferred Stock”) issued in connection with a private placement transaction, and (ii) 2,353,500 shares of common stock issuable upon exercise of warrants issued by the Registrant in a private placement transaction. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events.

(2)

This estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Registrant’s common stock on January 22, 2024, as reported on the Nasdaq Capital Market.